Ticker: AFL

Aflac

Finance Financials Insurance - Life
Price 113.94
Reco Hold Potential 46 Risk 62 Updated 2026-09-09

Forecast impact

limited
Target +6.3% target fill 94.0%
Reaction D5 -2.17% · D10 -4.32%
Impact Potential 0 · Risk 0 valid until 2026-09-18

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Aflac is a financial services company primarily focused on supplemental insurance products. Its core offerings include accident, cancer, critical illness, and short-term disability insurance. The company operates mainly in the United States and Japan, with significant revenue generated from premiums and investment income. Aflac is recognized for its strong brand presence in the supplemental insurance market, catering to both individual and group policyholders.

Investment Profile

Aflac's stock may appeal to investors seeking dividends, given its consistent dividend yield. The company's focus on supplemental insurance positions it as a stable player in the financial sector, though recent revenue declines may indicate challenges. This stock is suitable for those looking for a balanced investment approach, considering its dividend payments alongside potential for moderate growth.

Fundamental metrics (experimental) Updated: 2026-09-07
EPS (TTM) — earnings per share for the last 12 months, $
9.32
Revenue QoQ — quarter-over-quarter revenue growth
-5.4%
EPS surprise
-0.6%
20d volatility
1.2%
Dividend yield
2.1%
last ex-date
2026-08-19
AI recommendation changes
Date Before After Reason
2026-08-08 Buy Hold Weak fundamentals and negative momentum raise concerns.
2026-08-01 Hold Buy Weak revenue growth offsets positive price momentum.
2026-07-17 Buy Hold Mixed fundamentals with moderate momentum; hold for now.
Analyst forecasts
Date Analyst Action Target Price Then
2026-08-19 Wells Fargo Target Raised 120 → 122 121.73
2026-08-10 Piper Sandler Target Raised 130 → 138 124.61
2026-08-10 Mizuho Securities Target Raised 112 → 116 124.61
News Page 1 of 1
Travelers Chubb Aflac

Analysts Ritholtz Wealth Management highlight Travelers (TRV) as a top insurance stock following strong Q2 earnings

Travelers (TRV) has reported impressive earnings, significantly exceeding analyst expectations, which has led to a surge in its stock price. This performance highlights the strength of the insurance sector, particularly for companies that effectively leverage technology and maintain strong dividend growth.